Gene expression profiling and breast cancer care: What are the potential benefits and policy implications?
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 7 (6) , 380-389
- https://doi.org/10.1097/01.gim.0000170776.31248.75
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- GENETIC TESTING IN PRIMARY CAREAnnual Review of Genomics and Human Genetics, 2004
- Decision-making in early breast cancer: guidelines and decision toolsEuropean Journal Of Cancer, 2002
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001
- Cost Comparison of Mastectomy Versus Breast-Conserving Therapy for Early-Stage Breast CancerJNCI Journal of the National Cancer Institute, 2001
- Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UKPharmacoEconomics, 2001
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- A New Decision Model for Cost-Utility Comparisons of Chemotherapy in Recurrent Metastatic Breast CancerPharmacoEconomics, 1996